Valeant goes for the niches. Deliberately.
Eli Lilly still chopping positions – Eli Lilly and Co. plans to cut 200 sales and marketing support jobs Friday in its U.S. biomedicine group, with more than half of those cuts taking place in Indianapolis, a company spokesman confirmed Thursday. The cuts are the latest wave of the drugmaker’s previously announced plans to chop 5,500 jobs worldwide by the end of 2011 in response to financial pressures…more
InVentiv to be acquired by private equity firm.
Bayer gets new type of contraceptive approved – The Food and Drug Administration approved Natazia, which is the first in the U.S. to deliver doses of its two female hormones at four times during the drug’s 28-day treatment cycle, the agency said today in a statement…more. But then, what about that mystery recall of Yaz last year – who knew??
I don’t know, Mr Harper (Forbes) – isn’t it more accurate to say that an application has been rejected, rather than that a drug has been rejected, when a Complete Response Letter is issued? The semantics are important.
Down – like, seriously depressed? Get Some Help.
More doctors giving drug reps the cold shoulder. And, sunlit leaves in dark shadow (pic).
JUST FOR FUN
Astonishing stuff – A Showcase of 3-D Street Art Paintings. How do people do this?
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Leave a Reply